Browse Studies — Arctuva

Phase 2

MT2022-60: A Phase II Study of Pembrolizumab+ BEAM Conditioning Regimen Before Autologous Stem Cell Transplant (ASCT) Followed by Pembrolizumab Maintenance in Patients of Relapsed or Refractory Classic Hodgkin Lymphoma

This is a Phase 2 single arm study to evaluate efficacy and safety of Pembrolizumab before with BEAM ASCT followed by Pembrolizumab maintenance for 1 year. Pat…

Autologous Stem Cell TransplantClassic Hodgkin Lymphoma

Estimated

~$10 – $6,250

Masonic Cancer Center, University of MinnesotaNCT06377540

Phase 3

Randomized, Double-Blind Study of FOND (Fosaprepitant, ONdansetron, Dexamethasone) Plus Either Olanzapine 2.5 mg Versus 5 mg for the Prevention of Chemotherapy Induced Nausea and Vomiting in Patients Receiving High-dose Melphalan Conditioning: The FONDO-LOW Study

Patients who receive a chemotherapy called melphalan are at high risk of having nausea and vomiting. A medication called olanzapine has been shown to decrease …

Multiple MyelomaAutologous Stem Cell Transplantation

Estimated

~$10 – $6,250

Augusta UniversityNCT06588413

Protocol for a Research Sample Repository for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries

The primary purpose of the Research Sample Repository is to make blood samples available for research studies related to histocompatibility and hematopoietic c…

Autologous Stem Cell TransplantationAllogeneic Stem Cell TransplantationCellular Therapy+1 more

Estimated

~$10 – $1,125

Center for International Blood and Marrow Transplant ResearchNCT04920474

Protocol For A Research Database For Hematopoietic Stem Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries

The primary purpose of the Research Database is to have a comprehensive source of observational data that can be used to study HSC transplantation and cellular…

Autologous Stem Cell TransplantationAllogeneic Stem Cell TransplantationSolid Tumors+4 more

Estimated

~$10 – $1,125

Center for International Blood and Marrow Transplant ResearchNCT01166009